BIOTONE® EASE-Z Diabetics' Pain Relieving Foot Cream

Six-dimension breakdown

Why this scored 45/100

The EASE-Z Diabetics' Pain Relieving Foot Cream from BIOTONE combines zinc (barrier and skin-soothing), capsaicin (topical analgesic with modest evidence for diabetic neuropathy pain — Derry 2017 Cochrane review supports high-concentration capsaicin patches for post-herpetic and diabetic neuropathy but consumer-grade OTC concentrations show weaker signal), and menthol (TRPM8 counterirritant analgesia) in a formulation specifically indicated for diabetic foot pain and neuropathy symptoms. The formulation itself is competent and the indication is real (diabetic peripheral neuropathy is a well-established clinical concern), but the same scope problem as the EASE-Z Dry Skin variant applies here: this is a condition-specific medical adjunct for a chronic-disease population, not a biohacking or general-wellness recovery product. Diabetics with painful peripheral neuropathy need clinician-directed care — pharmacologic (gabapentinoids, SNRIs), interventional, and appropriate topical adjuncts — with monitoring, not consumer-platform recommendations. Vyvata is not the correct sales channel for medical-management adjuncts. Rejected under out_of_scope_for_biohacking on the same rationale as the sibling SKU: not a quality issue with the product, a fit issue with the platform. Would become listable at Standard 55+ only if repositioned as general-population topical foot-pain relief (dropping the diabetic-specific indication).

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

• 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
• 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
• 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
• 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
• 0–19: No credible evidence base or unverifiable claims.

FAQ data has not been generated for this product yet. See the site FAQ for general questions.

Customer reviews

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score

45 / 100

Tier

Rejected

Category

Recovery regeneration

Subcategory

contrast therapy

Last scored

August 30, 2026

Third-party certifications

None on record at time of scoring

Vendor

Orthopedic Outfitters

Product type

Gel, Lotion & Cream

Tags

Orthopedic Outfitters, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.